Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis

NCT06846385 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: MG-K10 Humanized Monoclonal Antibody Injection

Sponsor

Shanghai Mabgeek Biotech.Co.Ltd